Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-04

Clinical Trial Update: Semi-automatic Segmentation Method for Determining 177Lu-DOTATATE Tumor Dosimetry

View source ↗

Summary

A completed clinical trial evaluates a semi-automatic segmentation method to determine tumor dosimetry for 177Lu-DOTATATE in meningioma. The update emphasizes d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUTATHERA (Lutetium Lu-177 dotatate)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Meningioma | Status: COMPLETED